[Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
Hui Du(Shanxi Cardiovascular Hospital), Shihua Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Jiang(Peking University), Lei Song(Yanbian University), Yan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiuyu Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaorong Yin(Fujian Medical University), Minjie Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianpeng Wang, Jinghan Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Yin(Qingdao University)
PubMed
August 1, 2014
Cited by 0
Related Papers
Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging
|Nature Medicine|2024|156
MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction
|Radiology|2019|139
T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy
|JACC. Cardiovascular imaging|2021|114
Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure
|Journal of the American College of Cardiology|2011|105
Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study
|Journal of Cardiovascular Magnetic Resonance|2020|94